Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/28/23
End: 02/25/25
Due: 02/25/26
Phase: N/A
Priority: Normal
Start: 03/11/25
End: 11/30/26
Due: 11/30/27
Phase: N/A
Priority: Normal
Start: 11/06/24
End: 07/31/26
Due: 07/31/27
Phase: N/A
Priority: Normal
Start: 07/08/24
End: 03/31/26
Due: 03/31/27
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts | NCT05799157 | Veradermics, Inc. | user2@example.com | None | 2023-02-28 | 2025-02-25 | 2026-02-25 | - | - | 2025-07-14 |
| Safety and Efficacy of VDPHL01 in Males With AGA | NCT06972264 | Veradermics, Inc. | user2@example.com | None | 2025-03-11 | 2026-11-30 | 2027-11-30 | - | - | 2025-07-14 |
| Efficacy and Safety of VDPHL01 in Males With AGA | NCT06724614 | Veradermics, Inc. | user2@example.com | None | 2024-11-06 | 2026-07-31 | 2027-07-31 | - | - | 2025-07-14 |
| Safety and Efficacy of VDPHL01 in Males and Females with AGA | NCT06527365 | Veradermics, Inc. | user2@example.com | None | 2024-07-08 | 2026-03-31 | 2027-03-31 | - | - | 2025-07-14 |